Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Cancer Drug News Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice December 10, 2021 A drug commonly used to treat cancer can restore memory and cognitive function in mice…
Cancer Drug News Cancer costs US more than $156 billion annually, with drugs a leading expense December 10, 2021 Care for the 15 most prevalent types of cancer in the U.S. cost approximately $156.2…
Cancer Drug News FDA approves “glowing tumour” imaging drug to better identify ovarian cancer cells December 7, 2021 The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as pafolacianine, which…
Cancer Drug News By putting cancer cells to sleep, new drug could prevent tumour metastasis December 1, 2021 A new therapeutic approach prevents the growth of metastatic tumours in mice by forcing cancer…
Cancer Drug News FDA approve clinical trial of drug to treat eye cancer ‘from the inside out’ November 17, 2021 Mark McLaughlin, a researcher with the WVU Cancer Institute and Modulation Therapeutics Inc., USA, and…
Cancer Drug News Retrospective study finds that cancer drug also lowers blood glucose November 15, 2021 Dasatinib, a drug that often is used to treat certain types of leukaemia, may have…
Cancer Drug News Scientists identify potential new drug combination for children with incurable brain cancer November 9, 2021 Combining two existing cancer drugs could offer promise for some children with an incurable childhood…
Cancer Drug News Targeted drug shows activity against brain metastases in kidney cancer October 26, 2021 A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving…
Breast Cancer Sacituzumab govitecan receives positive CHMP opinion as 2L treatment for adult patients with metastatic triple-negative breast cancer October 21, 2021 The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for…
Cancer Drug News Pembrolizumab and lenvatinib receive positive EU CHMP opinions for two different types of cancer October 21, 2021 The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has…